Research spend on cancer doubles within a decade and the most fatal cancers see investment

Partners of the National Cancer Research Institute (NCRI) spent more than Ј500m on cancer research last year, nearly double the amount spent almost ten years ago, according to new figures. Partners of the National Cancer Research Institute (NCRI) spent more than Ј500m on cancer research last year, nearly double the amount spent almost ten years ago, according to new figures.

29 June 2011

• Charity News

Dame Janet Husband appointed chair of the National Cancer Research Institute

Dame Janet Husband has been appointed the new chair of the National Cancer Research Institute (NCRI). Dame Janet Husband has been appointed the new chair of the National Cancer Research Institute (NCRI).

1 April 2011

• Health & Medicine

HPV testing and vaccination could cut cervical screening to twice in a lifetime

Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool. Women who have had the human papillomavirus (HPV) vaccine could need only two HPV screening tests for the rest of their lives according to new calculations being presented at the NCRI Cancer Conference in Liverpool.

10 November 2010

• Health & Medicine

New kidney cancer surgery technique could reduce organ damage

A new method of surgery for kidney cancer could help reduce organ damage, leading to more successful treatment of the disease, scientists have discovered. A new method of surgery for kidney cancer could help reduce organ damage, leading to more successful treatment of the disease, scientists have discovered.

10 November 2010

Single gene target could boost bowel cancer survival by three months

Scientists have discovered a genetic region linked to survival in patients with advanced bowel cancer, according to a study being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Tuesday). Scientists have discovered a genetic region linked to survival in patients with advanced bowel cancer, according to a study being presented at the National Cancer Research Institute (NCRI) Cancer Conference today (Tuesday).

9 November 2010

• Health & Medicine

New Guide Can Predict Patients' Survival

A new way of predicting how long terminally ill cancer patients have to live, has been devised by Cancer Research UK-funded research. A new way of predicting how long terminally ill cancer patients have to live, has been devised by Cancer Research UK-funded research.

9 November 2010

• Health & Medicine

Recession saw fewer smokers quitting

Since the recession began the number of smokers quitting has fallen according to new research being presented at the NCRI Cancer Conference in Liverpool today (Tuesday). Since the recession began the number of smokers quitting has fallen according to new research being presented at the NCRI Cancer Conference in Liverpool today (Tuesday).

9 November 2010

• Health & Medicine

Data suggests too few lung cancer patients getting surgery

Only half as many lung cancer patients in England are getting potentially lifesaving surgery compared to the best countries in the world, according to a new report by the National Cancer Intelligence Network (NCIN). Only half as many lung cancer patients in England are getting potentially lifesaving surgery compared to the best countries in the world, according to a new report by the National Cancer Intelligence Network (NCIN).

8 November 2010

• Health & Medicine

Radiotherapy cuts deaths from high risk prostate cancer

MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool MEN TREATED with radiotherapy as well as hormone therapy for advanced prostate cancer were 43 per cent less likely to die from the disease, according to trial results presented at the NCRI Cancer Conference in Liverpool

8 November 2010

• Health & Medicine

Test selects the 60 per cent of women with inherited ovarian cancer who could benefit from 'smart' drug

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool. Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool.

8 November 2010

• Health & Medicine

Number of cancer patients taking part in clinical studies quadruples in a decade

The number of cancer patients in the UK participating in clinical studies has soared in the last decade from one in 26, to around one in six patients diagnosed, according to new figures presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week (Tuesday). The number of cancer patients in the UK participating in clinical studies has soared in the last decade from one in 26, to around one in six patients diagnosed, according to new figures presented at the National Cancer Research Institute (NCRI) Cancer Conference in Liverpool this week (Tuesday).

7 November 2010

UK's first dedicated prostate cancer virtual biobank launched

The first virtual biobank dedicated to prostate cancer research has been launched today by the National Cancer Research Institute (NCRI). The first virtual biobank dedicated to prostate cancer research has been launched today by the National Cancer Research Institute (NCRI).

7 November 2010